Pharmacokinetics of methylphenidate in hyperkinetic children.
Open Access
- 1 December 1979
- journal article
- Published by Wiley
- Vol. 8 (6) , 571-576
- https://doi.org/10.1111/j.1365-2125.1979.tb01046.x
Abstract
1 Pharmacokinetic study has been carried out following oral administration of 10-20 mg of methylphenidate hydrochloride to four behaviorally disorders children. 2 It is indicated that the drug is metabolized to ritalinic acid with an apparent plasma half life of 2.5 h. 3 The variability in magnitude of plasma concentration seems to be due not to its metabolism to ritalinic acid but due to the variability in the apparent volume of distribution. 4 The brief half life of methylphenidate which parallels the short duration of action of methylphenidate in behaviorally disordered children may be explained in part by its low protein binding which results in high percentage of free drug being made available for metabolism to pharmacologically inactive metabolites.Keywords
This publication has 22 references indexed in Scilit:
- Pharmacokinetics of Methylphenidate in the Rat Using Single-Ion Monitoring GLC-Mass SpectrometryJournal of Pharmaceutical Sciences, 1977
- Clinical Implications of Imipramine Plasma Levels for Depressive IllnessArchives of General Psychiatry, 1977
- Pharmacologic Management of Children with Hyperactive/Aggressive/Inattentive Behavior DisordersClinical Pediatrics, 1976
- The thermal decomposition of methylphenidate in the gas chromatograph mass spectrometerJournal of Mass Spectrometry, 1975
- A reproducible gas chromatographic mass spectrometric assay for low levels of methylphenidate and ritalinic acid in blood and urineJournal of Mass Spectrometry, 1975
- PLASMA-NORTRIPTYLINE LEVELS IN ENDOGENOUS DEPRESSIONThe Lancet, 1973
- PLASMA CONCENTRATION OF AMITRIPTYLINE AND CLINICAL RESPONSEThe Lancet, 1972
- Comparative Clinical Pharmacology of Local Anesthetic AgentsAnesthesiology, 1971
- A study of structure-activity relationships in regard to species difference in the phenylbutazone seriesBiochemical Pharmacology, 1964
- Ritalin, eine neuartige synthetische Verbindung mit spezifischer zentralerregender WirkungskomponenteKlinische Wochenschrift, 1954